Ex vivo anti-tumor activity of rosiglitazone on multiple myeloma cells.

被引：0
|
作者：
Huang, Haiwen
Wu, De Pei
Leung, Anskar Y. H.
Liang, Raymond
Lie, Albert K. W.
机构：
[1] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
[2] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5052
引用
收藏
页码：352B / 352B
页数：1
相关论文
共 50 条
  • [31] The anti-tumor activity of an anti-CD39 antibody (ES002) in a multiple myeloma model is dependent on NK cells
    Qiu, Yangsheng
    Du, Qinglin
    Sun, Meiling
    Gao, Rui
    Kong, Huimin
    Xing, Roumei
    Shi, Yufei
    Xu, Mengying
    Wu, Zhihao
    Lu, Hongtao
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [32] IAP antagonists induce anti-tumor immunity in multiple myeloma
    Chesi, Marta
    Mirza, Noweeda N.
    Garbitt, Victoria M.
    Sharik, Meaghen E.
    Dueck, Amylou C.
    Asmann, Yan W.
    Akhmetzyanova, Ilseyar
    Kosiorek, Heidi E.
    Calcinotto, Arianna
    Riggs, Daniel L.
    Keane, Niamh
    Ahmann, Gregory J.
    Morrison, Kevin M.
    Fonseca, Rafael
    Lacy, Martha Q.
    Dingli, David
    Kumar, Shaji K.
    Ailawadhi, Sikander
    Dispenzieri, Angela
    Buadi, Francis
    Gertz, Morie A.
    Reeder, Craig B.
    Lin, Yi
    Chanan-Khan, Asher A.
    Stewart, A. Keith
    Fooksman, David
    Bergsagel, P. Leif
    NATURE MEDICINE, 2016, 22 (12) : 1411 - +
  • [33] IAP antagonists induce anti-tumor immunity in multiple myeloma
    Marta Chesi
    Noweeda N Mirza
    Victoria M Garbitt
    Meaghen E Sharik
    Amylou C Dueck
    Yan W Asmann
    Ilseyar Akhmetzyanova
    Heidi E Kosiorek
    Arianna Calcinotto
    Daniel L Riggs
    Niamh Keane
    Gregory J Ahmann
    Kevin M Morrison
    Rafael Fonseca
    Martha Q Lacy
    David Dingli
    Shaji K Kumar
    Sikander Ailawadhi
    Angela Dispenzieri
    Francis Buadi
    Morie A Gertz
    Craig B Reeder
    Yi Lin
    Asher A Chanan-Khan
    A Keith Stewart
    David Fooksman
    P Leif Bergsagel
    Nature Medicine, 2016, 22 : 1411 - 1420
  • [34] Atherosclerosis Reduces Anti-Tumor Activity of Liver-Resident Natural Killer Cells.
    Imaoka, K.
    Ohira, M.
    Sato, K.
    Imaoka, Y.
    Nakano, R.
    Ohdan, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 885 - 885
  • [35] In Vivo Anti-Tumor Efficacy of Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®) in Multiple Myeloma.
    Sanchez, Eric
    Steinberg, Jeffrey A.
    Li, Mingjie
    Chen, Haiming
    Bonavida, Benjamin
    Deitcher, Steven R.
    Hagey, Anne E.
    Berenson, James R.
    BLOOD, 2008, 112 (11) : 952 - 953
  • [36] In vitro and in vivo anti-tumor activity of alectinib in tumor cells with NCOA4-RET
    Arai, Sachiko
    Kita, Kenji
    Tanimoto, Azusa
    Takeuchi, Shinji
    Fukuda, Koji
    Sato, Hiroshi
    Yano, Seiji
    ONCOTARGET, 2017, 8 (43) : 73766 - 73773
  • [37] Ex vivo generation and function of dendritic cells in multiple myeloma
    Pfeiffer, S
    Samson, D
    Apperley, J
    Gooding, R
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) : S364 - S364
  • [38] Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma
    Jakubikova, Jana
    Cervi, David
    Ooi, Melissa
    Kim, Kihyun
    Nahar, Sabikun
    Klippel, Steffen
    Cholujova, Dana
    Leiba, Merav
    Daley, John F.
    Delmore, Jake
    Negri, Joseph
    Blotta, Simona
    McMillin, Douglas W.
    Hideshima, Teru
    Richardson, Paul G.
    Sedlak, Jan
    Anderson, Kenneth C.
    Mitsiades, Constantine S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (08): : 1170 - 1179
  • [39] Anti-tumor activity of the proteasome inhibitor BSc2118 against human multiple myeloma
    Zang, Meirong
    Li, Zengjun
    Liu, Lanting
    Li, Fei
    Li, Xin
    Dai, Yun
    Li, Wei
    Kuckelkorn, Ulrike
    Doeppner, Thorsten R.
    Hermann, Dirk M.
    Zhou, Wen
    Qiu, Lugui
    Jin, Fengyan
    CANCER LETTERS, 2015, 366 (02) : 173 - 181
  • [40] BSC2118, a novel proteasome inhibitor with in vitro anti-tumor activity in multiple myeloma
    Sterz, J.
    Metzler, I. V.
    Kuckelkorn, U.
    Braun, H. A.
    Rotzer, S.
    Kaiser, M.
    Fleissner, C.
    Heider, U.
    Kloetzel, P. M.
    Sezer, O.
    Jakob, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 152 - 152
12345